Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3.
about
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.Prevalence of and risk factors for pre-diabetes in HIV-1-infected patients in Bangkok, Thailand.
P2860
Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@ast
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@en
type
label
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@ast
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@en
prefLabel
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@ast
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@en
P2093
P2860
P356
P1476
Safety and efficacy of a gener ...... ersus CD4 > or = 50 cells/mm3.
@en
P2093
Sirirat Likanonsakul
Sukanya Chimsuntorn
Weerawat Manosuthi
P2860
P2888
P356
10.1186/1742-6405-4-6
P577
2007-03-13T00:00:00Z
P5875
P6179
1028994264